SutroVax has received an award from CARB-X for up to $15 million in non-dilutive funding to develop a universal vaccine to prevent infections caused by Group A Strep bacteria...
The researchers say that a vaccine which was 80% effective and reached 90% of women could potentially prevent 231,000 infant and maternal cases of disease.